Le Lézard
Classified in: Health, Science and technology
Subjects: NPT, TDS, FVT

Ultimate Medical Academy to Sponsor and Participate at the 2019 Synapse Summit in Tampa


TAMPA, Fla., Jan. 22, 2019 /PRNewswire/ -- Ultimate Medical Academy, a nonprofit healthcare educational institution employing more than 2,000 people in the Tampa Bay area, is pleased to sponsor and participate in the upcoming Synapse Summit, which is focused on highlighting Tampa Bay's and Florida's strong growth in the areas of innovation and technology.

At the Synapse Summit several Ultimate Medical Academy leaders, including President Derek Apanovitch, CIO Jeremy Wilson, Senior Vice President April Neumann, and Senior Vice President of Strategic Initiatives Alexandra Schaffrath, will share how UMA is an innovator in training people for healthcare careers and partners with key business allies to develop highly skilled employees.

The 2019 Synapse Summit on Jan. 23-24 at the Amalie Arena in Tampa endeavors to bring together the best people, ideas, and technologies for two days of collaborating, exploring, and celebrating the possibilities of technology and innovation.  

At the summit several UMA leaders will share how UMA is an innovator in training people for healthcare careers and partners with key business allies to develop highly skilled employees.

The sponsorship is part of UMA's community involvement activities and support of attracting entrepreneurial and technology companies, as well as the best talent, to the Tampa Bay area.

"UMA's involvement in the summit underscores our commitment and dedication to the Tampa Bay community to support technology and innovation," Wilson noted. "Our participation in the summit also furthers our efforts to build awareness of UMA as a resource for healthcare talent, as well as a major employer in the Tampa Bay area."

ABOUT ULTIMATE MEDICAL ACADEMY
Ultimate Medical Academy is a nonprofit healthcare educational institution with a national presence. Headquartered in Tampa, Florida and founded in 1994, the school has more than 45,000 alumni and offers content-rich, interactive online courses to almost 15,000 students as well as hands-on training to hundreds of students. UMA students have access to academic advising, one-on-one or group tutoring, resume and interview coaching, job search assistance, technical support and more. UMA is institutionally accredited by the Accrediting Bureau of Health Education Schools (ABHES). Learn more by visiting https://www.ultimatemedical.edu/.

Like UMA on Facebook: https://www.facebook.com/umaonline/
Follow UMA on Twitter: https://twitter.com/UltimateMedical
Watch UMA on YouTube: https://www.youtube.com/channel/UCZKEpFCt6DQKM_eyZ3jJhGw
Follow UMA on Instagram: https://www.instagram.com/ultimatemedicalacademy/

ABOUT SYNAPSE
The Innovation Summit is a production of Synapse. The overall vision of Synapse is to be an all-encompassing, interactive, and flexible methodology for building, facilitating and exposing the Entrepreneurial Ecosystem of Florida. Learn more by visiting, https://synapsefl.com/

SOURCE Ultimate Medical Academy


These press releases may also interest you

at 07:55
The "KEYTRUDA Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering. The report provides comprehensive insights about KEYTRUDA for ovarian cancer in the seven major markets. A detailed...

at 07:50
The "Peptide Synthesis Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Type of Peptide Synthesis Method, Type of Chemical Synthesis, Contract Manufacturing Organization Size, Key Geographical Regions" report has been added to...

at 07:45
The "Laboratory Filtration Equipment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. Global Laboratory Filtration Equipment Market to Reach $3 Billion by 2030 The global market for Laboratory...

at 07:40
The "Global Weight Loss Drugs Market: Analysis By Product Type, By Drug Type, By Distribution Channel, By End User, By Region, Size and Trends with Impact of COVID-19 and Forecast up to 2029" report has been added to ResearchAndMarkets.com's...

at 07:35
Arrowhead Pharmaceuticals, Inc. today announced its plan to host a 2024 Summer Series of R&D webinars that highlight multiple clinical stage RNA interference (RNAi) based medicines that utilize the company's proprietary Targeted RNAi Molecule...

at 07:35
Reports First-Quarter Diluted EPS of $0.77 on a GAAP Basis, an Increase of 492.3 Percent; Adjusted Diluted EPS of $2.31, a Decrease of 6.1 Percent; These Results Include an Unfavorable Impact of $0.08 Per Share Related to Acquired IPR&D and...



News published on and distributed by: